(Q40430977)

20 September 2017

1 reference

title

Clinical pharmacokinetics and efficacy of renin inhibitors (English)

1 reference

20 September 2017

Clinical Pharmacokinetics and Efficacy of Renin Inhibitors (English)

1 reference

10.2165/00003088-199529010-00002

Crossref

DOI

https://api.crossref.org/works/10.2165/00003088-199529010-00002

26 May 2024

1 reference

G. A. Rongen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586899

26 May 2024

J. W. Lenders

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586899

26 May 2024

P. Smits

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586899

26 May 2024

T. Thien

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586899

26 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7586899

26 May 2024

publication date

1 July 1995

1 reference

full work available at URL

20 September 2017

https://repository.ubn.ru.nl/bitstream/2066/21693/1/21693___.PDF

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586899

Clinical Pharmacokinetics

26 May 2024

published in

1 reference

20 September 2017

volume

29

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

6-14

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199529010-00002

20 September 2017

exact match

0 references

cites work

The antihypertensive effect of captopril in essential hypertension: relationship to prostaglandins and the kallikrein-kinin system

1 reference

12 December 2020

Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension

1 reference

12 December 2020

A study of the renin inhibitor H142 in man

1 reference

12 December 2020

Inhibition of the renin-angiotensinogen reaction by pepstatin

1 reference

12 December 2020

Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension

1 reference

12 December 2020

Effect of renin inhibitor, ES-8891, on renal renin secretion and storage in the marmoset: comparison with captopril

1 reference

12 December 2020

Discovery of a well-absorbed, efficacious renin inhibitor, A-74273

1 reference

12 December 2020

Hemodynamic and humoral effects of the new renin inhibitor enalkiren in normal humans

1 reference

12 December 2020

The effect of the renin inhibitor ES-1005 on the expression of the kidney renin gene in sodium-depleted marmosets

1 reference

12 December 2020

Hemodynamics, biochemical effects, and pharmacokinetics of the renin inhibitor remikiren in healthy human subjects

1 reference

12 December 2020

Prolonged duration of blood pressure response to enalkiren, the novel dipeptide renin inhibitor, in essential hypertension

1 reference

12 December 2020

Intrapulmonary delivery of renin inhibitory peptides results in sustained release because of saturable transport

1 reference

12 December 2020

Molecular mechanisms of renin release

1 reference

12 December 2020

Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers

1 reference

12 December 2020

Different patterns of release of endothelium-derived relaxing factor and prostacyclin

1 reference

12 December 2020

Antihypertensive efficacy of FK906, a novel human renin inhibitor

1 reference

12 December 2020

The site of angiotensin production

1 reference

12 December 2020

The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

1 reference

12 December 2020

Discovery of remikiren as the first orally active renin inhibitor.

1 reference

12 December 2020

Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans

1 reference

12 December 2020

Angiotensin-converting enzyme and the cough reflex

1 reference

12 December 2020

Human renin inhibitor peptides

1 reference

12 December 2020

Neurohormonal and Blood Pressure Responses to Low-Dose Infusion of an Orally Active Renin Inhibitor, Ro 42-5892, in Salt-Replete Men

1 reference

12 December 2020

Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients.

1 reference

12 December 2020

Clinical pharmacology of enalkiren, a novel, dipeptide renin inhibitor

1 reference

12 December 2020

Distribution volume and metabolic clearance rate of renin in anesthetized nephrectomized dogs.

1 reference

12 December 2020

Combined renin and converting enzyme inhibition in rats.

1 reference

12 December 2020

Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients

1 reference

12 December 2020

Pharmacokinetics and tissue distribution of the renin inhibitor N-(2-(R)-benzyl-3-tert-butyl-sulfonyl-propionyl)-His-ChacVal-n-butylami ne in marmosets

1 reference

12 December 2020

Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers.

1 reference

12 December 2020

Renin and renin inhibition in anephric man

1 reference

12 December 2020

Characterization of angiotensin peptides in plasma of anephric man

1 reference

12 December 2020

Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan

1 reference

12 December 2020

Assessment of renin dependency of hypertension with a dipeptide renin inhibitor

1 reference

12 December 2020

Oral delivery of a renin inhibitor compound using emulsion formulations

1 reference

12 December 2020

Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo

1 reference

12 December 2020

Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a renin inhibitor). II: A dose-ranging study in patients with congestive heart failure

1 reference

12 December 2020

Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator

1 reference

12 December 2020

ES-8891, an orally active inhibitor of human renin

1 reference

12 December 2020

Hepatocellular uptake of peptides--II. Interactions between hydrophilic linear renin-inhibiting peptides and transport systems for endogenous substrates in liver cells

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension

1 reference

12 December 2020

Hepatocellular uptake of peptides--I. Carrier-mediated uptake of hydrophilic linear peptides with renin inhibitory activity into isolated rat liver cells

1 reference

12 December 2020

Renin release regulation during acute renin inhibition in normal volunteers

1 reference

12 December 2020

Interleukin 1 and the glomerular mesangium. III. IL-1-dependent stimulation of mesangial cell protein kinase activity

1 reference

12 December 2020

Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure

1 reference

12 December 2020

Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy

1 reference

12 December 2020

Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system

1 reference

12 December 2020

Comparative effects of three different potent renin inhibitors in primates

1 reference

12 December 2020

Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure

1 reference

12 December 2020

CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Efficacy and tolerability of the renin inhibitor Ro 42-5892 in patients with hypertension

1 reference

12 December 2020

Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat

1 reference

12 December 2020

Nephrectomy, converting enzyme inhibition, and angiotensin peptides

1 reference

12 December 2020

Hemodynamic effects of a competitive renin inhibitory peptide in humans: evidence for multiple mechanisms of action

1 reference

12 December 2020

Multiple dose pharmacokinetics and concentration effect relationship of the orally active renin inhibitor remikiren (Ro 42-5892) in hypertensive patients

1 reference

12 December 2020

R-PEP-27, a potent renin inhibitor, decreases plasma angiotensin II and blood pressure in normal volunteers

1 reference

12 December 2020

Effects of an orally active renin inhibitor, Ro 42-5892, in patients with essential hypertension.

1 reference

12 December 2020

Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?

1 reference

12 December 2020

Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of enalkiren (Abbott-64662, a new renin inhibitor). I: Single dose study

1 reference

12 December 2020

10.2165/00003088-199529010-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1034910753

0 references

1 reference